Lucie Hwang MSc. PharmD.

Founder & Chief Executive Officer

Lucie is a pharmaceutical doctor graduated from the Paris Cite (Descartes) University in France, specialised in Research and Development for biotherapeutics.

She started working on the regulatory science of cell and gene therapies and further acquired high level experiences on the global development strategy of innovative technologies at early stage.

With her expertise, Lucie is accompanying start-up companies developing new products treating various diseases with unmet medical need in EU and US.

Professional History

• Paris Cite (Descartes) University, Pharmaceutical Doctor specialised in Research and Development of Biotherapeutics (certified to register on the list B of the Order of Pharmacists as “Pharmacien Responsable” the legal French Chief Pharmaceutical Officer) - acquired with Magna Cum Laude

• Paris Cite (Descartes) University & ParisTech Institute, Master of Bio-Medical Engineering, Cellular and Molecular Biotherapies - acquired with Magna Cum Laude

• Registered Pharmacist in Paris Community Pharmacies - Paris France

• APHP (Public Assistance of Paris Hospitals) Saint-Antoine Hospital Pharmacy, Anti-Cancer Unit, Medical Imaging Unit - Paris France

• ANSM (French Health Authority), Clinical Evaluation Unit of Cell Preparations, Human Organ Transplants and Vaccines - Paris France

• MSD France (Merck Sharp & Dohme Co.), Global Clinical Trial Operation Unit - Paris France

• EMA (European Medicines Agency), Scientific Evidence Generation Department, Orphan Medicines Office - London UK

• Alan Boyds – Global top leading consulting company for early-stage development in UK and US - Cambridge UK

• Voisin Life Sciences – Global top leading consulting company for early-stage development in EU and US - Paris France